UK Cancer Drugs Fund Debuts To Muted Applause From Pharma, Charities

The re-launch of the controversial Cancer Drugs Fund in the UK has offered another point for debate about cancer drug pricing, budgetary pressures and the cost of innovation.

SC1607_CureCancerButton_1200x675

Pharma and charities in the UK gave a lukewarm welcome to the formal launch of the revamped Cancer Drugs Fund, saying the new entity – controlled by the National Institute For Health and Clinical Excellence (NICE) – will not solve underlying problems of drug reimbursement which, in turn, restrict access to novel oncology therapies.

NHS England earlier in July issued new guidelines on how cancer drugs will be appraised and funded in the UK,...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United Kingdom

More from Europe